Abstract:Metastatic progression of cancer is a complex and clinically daunting process, with migration, invasion and angiogenesis being the key features. Tetrandrine (TET) is a typical dibenzylisoquinoline alkaloid with promising anti-tumor activity. In our previous work, a number of TET derivatives were designed and synthesized with obvious anti-proliferation activities against cancer cells, however, the anti-metastatic effects of these compounds were not evaluated. In the current investigation, five TET derivatives (8, 18, 32, 71, and 72) with pronounced anti-proliferative activities (IC50 values of 1.00, 1.91, 3.43, 3.78, and 1.93 μM, respectively) against human umbilical vein endothelial cells (HUVECs) were screened out. Scratch assays showed that these compounds significantly suppressed the migration of HUVECs and induced their apoptosis. Among them, derivatives 8 and 72 obviously inhibited the proliferation, colony formation and invasion of HCT-15 cells. Tube formation assays revealed that 4 μM of 8 or 72 remarkably inhibited the tube forming capacity of HUVECs. Moreover, 8 and 72 surpressed the formation of filopodia in HUVECs and severely impaired their motility. Both compounds effectively inhibited the angiogenesis in the zebrafish model with low toxicities in vivo. These results indicated that TET derivatives 8 and 72 are promising anti-metastatic inhibitors.

Discovery of Antimetastatic Chiral Ionone Alkaloid Derivatives Targeting HIF‐1α/VEGF/VEGFR2 Pathway

Synthesis and anti-metastatic effects of novel chiral ionone alkaloid derivatives

Alkaloid Derivative ION-31a Inhibits Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α.

Alkaloid Derivative (Z)-3Β-ethylamino-pregn-17(20)-en Inhibits Triple-Negative Breast Cancer Metastasis and Angiogenesis by Targeting HSP90α

Synthesis and anti-metastatic effects of pregn-17(20)-en-3-amine derivatives.

Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea derivatives against breast cancer by inhibiting PI3K/Akt/mTOR and Hedgehog signalings.

Synthesis and Antitumor Invasive Activity of Novel Ionone Alkaloid Derivatives

Discovery of 1-(3-aryl-4-chlorophenyl)-3-(p-aryl)urea Derivatives Against Breast Cancer by Inhibiting PI3K/Akt/mTOR and Hedgehog Signalings

A New Chiral 2-(Ethylthio)-thiazolone Analogue Shows Strong Antitumor Activities by Inducing Cancer Cell Apoptosis and Inhibiting Angiogenesis.

Discovery of Novel Steroidal-Chalcone Hybrids with Potent and Selective Activity Against Triple-Negative Breast Cancer.

Discovery of Novel Aryl Carboxamide Derivatives As Hypoxia-Inducible Factor 1α Signaling Inhibitors with Potent Activities of Anticancer Metastasis.

Optimization of 2-(3-(arylalkyl amino carbonyl) phenyl)-3-(2-methoxyphenyl)-4-thiazolidinone derivatives as potent antitumor growth and metastasis agents.

Design, Synthesis, and Biological Evaluation of Harmine Derivatives As Topoisomerase I Inhibitors for Cancer Treatment

Discovery of Ureido-Substituted 4-Phenylthiazole Derivatives as IGF1R Inhibitors with Potent Antiproliferative Properties

Discovery of a Novel Piperlongumine Analogue As a Microtubule Polymerization Inhibitor with Potent Anti-Angiogenic and Anti-Metastatic Efficacy.

Vi-14, A Novel Flavonoid Derivative, Inhibits Migration and Invasion of Human Breast Cancer Cells

Chamaejasmenin B, a novel candidate, inhibits breast tumor metastasis by rebalancing TGF-beta paradox

Synthesis and Biological Evaluation of Indole-2-carbohydrazide Derivatives As Anticancer Agents with Anti-angiogenic and Antiproliferative Activities.

Discovery and Optimization of N-Substituted 2-(4-pyridinyl)thiazole Carboxamides Against Tumor Growth Through Regulating Angiogenesis Signaling Pathways

Discovery of tetrandrine derivatives as tumor migration, invasion and angiogenesis inhibitors

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents